Search

Effects of the system temperature on dust aggregation in plasmas are investigated using two-dimensional molecular dynamics simulations. It is shown that as the system temperature increases, the boundary of the clusters becomes gradually irregular (i.e., deviating from sphere-like), and the cluster system gradually changes from solid to liquid and finally to gas state. The mean square displacement, mean nearest-neighbor distance in the clusters, cluster size and coupling parameter of the system are obtained and the properties of the system structure and dynamics are investigated. The time τ needed for reaching equilibrium for different temperatures is obtained. It is shown that τ firstly decreases and then increases with the temperature, indicating that there is an optimum temperature allowing a dust aggregation to reach an equilibrium state most rapidly. The simulation results agree qualitatively with the experimental observations. (© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim) [ABSTRACT FROM AUTHOR]

Sixteen laboratories from 10 different countries participated in an international collaborative study to evaluate candidate materials as the first World Health Organization (WHO) International Standard for hepatitis A virus (HAV) RNA nucleic acid amplification technology (NAT) assays.Five candidate materials were analysed in this study: materials AA and BB were lyophilized, while materials CC, DD and EE were liquid preparations. Samples were diluted in pooled plasma or in pooled cryo-poor plasma (sample EE). Serial dilutions of the candidate materials were tested by each laboratory in four independent assays and the results were analysed statistically.The mean log10‘equivalents’ per ml were 5·29 for sample AA, 5·07 for sample BB, 4·99 for sample CC, 5·40 for sample DD and 4·08 for sample EE.Based on the results of this study, sample AA was established as the first International Standard for HAV RNA NAT assays at the WHO Expert Committee on Biological Standardizaton (ECBS) meeting held in February 2003. The code number of this preparation is 00/560 and the potency, based on the study, is 100 000 International Units (IU)/ml. [ABSTRACT FROM AUTHOR]

The article discusses gastric glomangiomyoma. Glomus tumours, are uncommon mesenchymal tumours with an incidence of about 1.6% among soft tissue tumours. The tumours are most commonly found in the peripheral soft tissues, especially in the distal parts of the extremities. Glomangiomyoma is a variant of glomus tumour. In the case study of a 54 year old Chinese Woman, she was presented with recurrent epigastric pain for two years. Repeated endoscopies revealed no mucosal lesion but only vague bulging in the posterior wall of the gastric antrum. Microscopically, the tumour showed a biphasic pattern.

A patient with gonadal dysgenesis was found to have a mucinous epithelial ovarian tumour on the left side and a streak gonad on the right. The preponderance of mucinous tumours (5 of 8) over other epithelial tumours in these patients is noted but the significance is not fully understood. Two models of pathogenesis (incessant ovulation and hypergonadotrophic hypogonadism) were proposed but neither satisfactorily explains the development of the tumours. Further ultrastructural, chromosomal and molecular biological study of these tumours may help to elucidate the underlying cause and pathogenesis.

Commercial concentrates of factor VIII (FVIII) were analyzed in order to 1) determine the effects of viral inactivation on von Willebrand factor (vWF); 2) evaluate the vWF content of the new, immunopurified concentrates; and 3) assess their potential for correcting the long bleeding time of von Willebrand disease (vWD). Included in our study were products that had been treated to inactivate viruses; older, untreated products; and the new, immunopurified concentrates. We measured von Willebrand factor antigen (vWF:Ag), ristocetin cofactor activity (RCoF), and vWF multimeric and subunit composition. A newly developed radioimmunoassay (RIA) was used to quantitate vWF:Ag. The vWF:Ag content varied from 0.083 micrograms/IU FVIII:C for Hemofil M to 32.2 micrograms/IU FVIII:C for Humate-P, whereas pooled normal human plasma (NHP) contained 6.3 micrograms/IU FVIII:C. The RCoF varied from 0.0007 to 2.09 U/IU FVIII:C, with the immunopurified concentrates having the lowest values and Humate-P the highest. The ratio of RCoF to vWF:Ag ranged from 11 to 96 U/mg, as compared to a ratio of 160 for NHP. All of the concentrates lacked the largest vWF multimers, and all had abnormal triplet patterns. Modest differences between some untreated concentrates and their treated counterparts were noted. As expected, the immunopurified concentrates had much lower levels of all vWF activities than the conventionally prepared products. Our data suggest that none of the concentrates have as great a capacity as NHP to correct the prolonged bleeding time of von Willebrand disease.